Next Article in Journal
Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis
Next Article in Special Issue
Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study
Previous Article in Journal
Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
Previous Article in Special Issue
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 650; https://doi.org/10.3390/vaccines10050650
Action Date Notes Link
article pdf uploaded. 20 April 2022 16:30 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/650/pdf-vor
article xml file uploaded 21 April 2022 08:25 CEST Original file -
article xml uploaded. 21 April 2022 08:25 CEST Update -
article pdf uploaded. 21 April 2022 08:25 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/650/pdf-vor
article supplementary file uploaded. 21 April 2022 08:25 CEST - https://www.mdpi.com/2076-393X/10/5/650#supplementary
article html file updated 21 April 2022 08:26 CEST Original file -
article xml file uploaded 22 April 2022 05:54 CEST Update -
article xml uploaded. 22 April 2022 05:54 CEST Update https://www.mdpi.com/2076-393X/10/5/650/xml
article pdf uploaded. 22 April 2022 05:54 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/650/pdf
article html file updated 22 April 2022 05:56 CEST Update -
article html file updated 2 August 2022 19:56 CEST Update https://www.mdpi.com/2076-393X/10/5/650/html
Back to TopTop